TickerFactsScreenerDevelopers

Lexaria Bioscience Corp. (LEXX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2009: $330.2K2010: $63.0K2011: $31.2K2012: $180.5K2013: $65.5K2014: $703.0K2015: $260.1K2016: $93.4K2017: $2.53M2018: $1.73M2019: $1.29M2020: $1.29M2021: $10.92M2022: $5.81M$5.81M
2009Cash & Equivalents (USD)2022
Fiscal YearCash & EquivalentsChange YoY
2022$5.81M-46.8%
2021$10.92M+743.9%
2020$1.29M+0.7%
2019$1.29M-25.6%
2018$1.73M-31.8%
2017$2.53M+2612.1%
2016$93.4K-64.1%
2015$260.1K-63.0%
2014$703.0K+972.6%
2013$65.5K-63.7%
2012$180.5K+478.6%
2011$31.2K-50.5%
2010$63.0K-80.9%
2009$330.2K—